quite curious. Amp 945 has ODD status in two areas - pancreatic cancer and lung fibrosis - I’m thinking IND is to cover clinical trials but they’ve already commenced and the drug is safe and tolerable (with promising signs of efficacy) so this ought to be an administrative process. I wonder if there’s some details they need to address. I guess this can run in parallel but I’m not an expert.
Ann: Pause in Trading, page-4
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $39.84M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 14.5¢ | $47.81K | 319.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 161129 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| ATX (ASX) Chart |